A
Power Law company profile
Amicogen
Health · South Korea · Founded 2000 · IPO 2013 Thoroughbred
Valuation
$157M
Market cap · May/2026
Revenue
$35M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
1 investor on Amicogen's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
1 investor entered at this stage
Global footprint
Where Amicogen has talent and traffic
Workforce by country
1
countries with
team presence
team presence
🇰🇷 South Korea100%
Web traffic by country
5.7K
monthly visits
across markets
across markets
🏳️ Korea228.1%
🏳️ Republic of0%
Market sentiment
What the market is saying about Amicogen
An AI-synthesized read of the highest-engagement posts about Amicogen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Amicogen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.